Codiak BioSciences (CDAK) executive Konstantinov sold 9,364 shares for $1,874 at an average $0.20
Insider transactions reported
Konstantin Konstantinov (executive at Codiak BioSciences Inc., CDAK) reported that they sold 9,364 shares for $1,874 at an average $0.20 on Mar 28, 2023. After these transactions the filing shows 0 shares held directly.
- Reporting person
- Konstantinov Konstantin
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 28, 2023 | Open-market sale (S) | Common Stock1 | -9,364 | avg $0.20 | $1,874 | 0 direct |
Holdings before and after
- Common Stock: 9,364 to 0 direct
Footnotes from the filing
- 1. Includes an aggregate of 1,932 shares of common stock acquired on June 30, 2022 and December 30, 2022 under the Issuer's Employee Stock Purchase Plan (ESPP).
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Konstantinov report in this CDAK Form 4?
Konstantin Konstantinov (executive at Codiak BioSciences Inc., CDAK) reported that they sold 9,364 shares for $1,874 at an average $0.20 on Mar 28, 2023. After these transactions the filing shows 0 shares held directly.
How many CDAK shares does Konstantinov hold after this filing?
The filing shows 0 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this CDAK insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for CDAK
Earlier insider filings at CDAK
- Mar 30, 2023SEC Form 4 filed by Bain Linda
- Mar 30, 2023SEC Form 4 filed by Barna Nicole
- Mar 30, 2023SEC Form 4 filed by Williams Douglas E
- Feb 21, 2023SEC Form 4: Bain Linda converted options into 15,226 shares and sold $6,753 worth of shares (4,934 units at $1.37), increasing direct ownership by 330% to 13,412 units to cover taxes
- Feb 21, 2023SEC Form 4: Bernstein Karen converted options into 8,750 shares
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Listed since
- 2020
Follow CDAK and get a push notification the moment its next story breaks.